FedQuery

Amgen USA INC

UEI XPGNQMXHP493 · CA · subsidiary of Amgen USA INC · SAM.gov record ↗

$149.9M
FY2025 obligations
7
Contract awards
Feb 25, 2020
First action
Jun 30, 2026
Latest action

Obligations by agency

  • Department Of Health And Human Services$149.9M
  • Department Of Veterans Affairs$-64K

Obligations by NAICS

Monthly obligations

Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jul 26

Largest awards

  • EXERCISE OPTION PERIOD 3 CLINS 0010, 0011, AND 0012.

    Ends
    Sep 28, 2032
    Started
    Sep 29, 2022
    Agency
    Office Of Assistant Secretary For Preparedness And Response
    NAICS
    541714
  • INCORPORATE 2025 FEDERAL CEILING PRICES INTO CONTRACT. NO CHANGES TO NATIONAL CONTRACT PRICES.

    Ends
    Started
    Feb 25, 2020
    Agency
    Department Of Veterans Affairs
    NAICS
    325412
  • NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.

    Ends
    Started
    Nov 14, 2025
    Agency
    Department Of Veterans Affairs
    NAICS
    325412
  • FSS

    Ends
    Started
    Jan 31, 2021
    Agency
    Department Of Veterans Affairs
    NAICS
    325412
  • 2 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERIODS.

    Ends
    Started
    Feb 25, 2025
    Agency
    Department Of Veterans Affairs
    NAICS
    325412
  • DE-OBLIGATE FUNDING FOR CONTRACT CLOSEOUT.

    Ends
    Dec 15, 2024
    Started
    Mar 11, 2024
    Agency
    Office Of Assistant Secretary For Preparedness And Response
    NAICS
    541714
  • TAVNEOS (AVACOPAN)

    Ends
    Sep 29, 2024
    Started
    Sep 30, 2023
    Agency
    Department Of Veterans Affairs
    NAICS
    325412